Open Access. Powered by Scholars. Published by Universities.®
- Institution
-
- Rowan University (37)
- LSU Health Science Center (24)
- Children's Mercy Kansas City (18)
- Thomas Jefferson University (16)
- University of Texas Rio Grande Valley (16)
-
- Philadelphia College of Osteopathic Medicine (11)
- Tower Health (7)
- Himmelfarb Health Sciences Library, The George Washington University (6)
- Providence (6)
- University of Nevada, Las Vegas (6)
- DePaul University (4)
- Virginia Commonwealth University (4)
- Cedarville University (3)
- Purdue University (3)
- Roseman University of Health Sciences (3)
- Western University (3)
- Arcadia University (2)
- Florida International University (2)
- Georgia State University (2)
- Murray State University (2)
- Wright State University (2)
- East Tennessee State University (1)
- Harrisburg University of Science and Technology (1)
- Kennesaw State University (1)
- Mississippi University for Women (1)
- Portland State University (1)
- SUNY Geneseo (1)
- University of Kentucky (1)
- University of Northern Iowa (1)
- Western Washington University (1)
- Keyword
-
- Cancer (13)
- Neoplasms (12)
- Multiple Myeloma (6)
- Oncology (5)
- Drug Resistance (4)
-
- Medicine (4)
- Antineoplastic Agents (3)
- Breast cancer (3)
- COVID-19 (3)
- Glioblastoma (3)
- HCC (3)
- Hepatocellular carcinoma (3)
- Liver (3)
- Melanoma (3)
- Myeloid Cell Leukemia Sequence 1 Protein (3)
- Screening (3)
- Skin cancer (3)
- Anastomotic Leak (2)
- Apoptosis (2)
- Bortezomib (2)
- Cardiotoxicity (2)
- Case report (2)
- Chemotherapy (2)
- Child (2)
- Cystectomy (2)
- Early Detection of Cancer (2)
- Epigenetics (2)
- Flavonoid (2)
- HPV (2)
- Health Services Accessibility (2)
- Publication Year
- Publication
-
- Rowan-Virtua Research Day (37)
- Medical Student Research Poster Symposium (24)
- Research Days (18)
- Research Symposium (16)
- Pancreatic Cancer & Related Diseases Symposium (11)
-
- Research Day (11)
- GW Research Days 2016 - 2020 (6)
- Tower Health Research Day (6)
- Health Equity and Quality Improvement (HEQI) Summit (5)
- Undergraduate Research Opportunities Program (UROP) (5)
- Biology and Medicine Through Mathematics Conference (4)
- Grace Peterson Nursing Research Colloquium (4)
- Annual Research Symposium (3)
- The Research and Scholarship Symposium (2013-2019) (3)
- AMNET XX Conferencia Internacional (2)
- Capstone Showcase (2)
- Georgia State Undergraduate Research Conference (2)
- Medical Student Research Symposium Abstracts and Posters (2)
- Posters-at-the-Capitol (2)
- Providence Nursing Research Conference 2023 – Present (2)
- St. Joseph Hospital, Orange, CA. Evidence Based Practice Conference (2)
- The Summer Undergraduate Research Fellowship (SURF) Symposium (2)
- Undergraduate Student Research Internships Conference (2)
- 2022 Providence Nurse Research Conference (1)
- Central Division Nurse Clinical Inquiry Conference (1)
- Commonwealth Computational Summit (1)
- Engagement & Service-Learning Summit (1)
- Epsilon Sigma at-Large Research Conference (1)
- Future Directions in Feminist Phenomenology (1)
- GREAT Day Posters (1)
Articles 181 - 186 of 186
Full-Text Articles in Medicine and Health Sciences
Coping With Pediatric Cancer: Conversational Methods Utilized By Parents And Children When Dealing With Pediatric Cancer, Chelsi Morgan Walls
Coping With Pediatric Cancer: Conversational Methods Utilized By Parents And Children When Dealing With Pediatric Cancer, Chelsi Morgan Walls
Graduate Research Symposium (GCUA) (2010 - 2017)
This thesis sought to analyze how parents communicate with their child regarding pediatric cancer treatments. When dealing with pediatric cancer, it is vital that parents and their child communicate about the illness in order to effectively cope with the cancer. Using Uncertainty Management Theory, along with sub-concepts of the theory (i.e., appraisals, inferences, and illusions), this thesis sought to discover which coping mechanism (i.e., affect-management or buffering) would be chosen to manage the illness. Under UMT, appraisals were assessed, resulting in positive and negative appraisal, which indicated whether the individual handled the issue with either an inference based on general …
Cell Migration Dynamics After Alteration Of Cell-Cell Contacts In Fibrosarcoma And Glioblastoma Cell Lines, Hassan S. Rizvi, Ronald K. Gary
Cell Migration Dynamics After Alteration Of Cell-Cell Contacts In Fibrosarcoma And Glioblastoma Cell Lines, Hassan S. Rizvi, Ronald K. Gary
Undergraduate Research Opportunities Program (UROP)
Cell migration is a vital component of metastasis. In this study, our intent was to study cell migration by alteration of the Wnt/GSK-3 Pathway. Since BeSO4 is a known GSK-3 kinase inhibitor, we hypothesized that this agent would cause cell migration to decrease as a result of β-catenin stabilization. Two human cell lines, HT-1080 (fibrosarcoma) and A172 (glioblastoma), were used to observe migration levels in the presence and absence of BeSO4. Our results show that cell migration is diminished for cells that were pre-treated with BeSO4, in comparison to the untreated (control) cells.
Synthesis Of Novel Aromatic Quinols For Colon And Renal Cancers, Bradley J. Davey, Tae Soo Jo, Pradip K. Bhowmik
Synthesis Of Novel Aromatic Quinols For Colon And Renal Cancers, Bradley J. Davey, Tae Soo Jo, Pradip K. Bhowmik
Undergraduate Research Opportunities Program (UROP)
Colon Cancer: The third most common cancer in USA. More than 1 million Americans currently living with colon cancer. 148,810 new cases expected in 2010. 50,000 deaths annually.
Renal Cancer: Approximately 58,000 people diagnosed in USA annually. Seventh most common cancer and tenth most common cause of cancer related death in men.
Aromatic quinols have demonstrated in vitro antitumor activity. Three heteroaromatic quinols show antitumor activity.
Pdest Fg12-Cmv Dsred Vector, Jarod Wolffis, Sheri L. Holmen
Pdest Fg12-Cmv Dsred Vector, Jarod Wolffis, Sheri L. Holmen
Undergraduate Research Opportunities Program (UROP)
Melanoma is the most rapidly increasing malignancy among young people in the United States. If detected early, the disease is easily treated; however, once the disease has metastasized it is largely refractory to conventional therapies and is associated with a high mortality rate. The development of human cancer from a pre-malignant primary tumor to a metastatic lesion that develops at secondary sites is thought to be a multi-step process, requiring many genetic and epigenetic events that provide a growth advantage to cells. It is still unclear which of the many genetic changes in human cancers are required for metastasis. Therefore, …
Expression Of An Alternate Splice Form Of Bmi-1 In Multiple Myeloma, Adam Austin, Kristine Veys, Debbie Wong, James Tung
Expression Of An Alternate Splice Form Of Bmi-1 In Multiple Myeloma, Adam Austin, Kristine Veys, Debbie Wong, James Tung
Undergraduate Research Opportunities Program (UROP)
The concept of “tumor stem cells” has garnered much attention in the last few years. Tumor stem cells are believed to exist among a heterogeneous group of cells that constitute a tumor. These tumor stem cells often express genes that are important for stem cell function, cell division, and maintenance of pluripotent state in stem cells. Stem cell or stem cell maintenance genes such as SALL 4 and Bmi-1 are often seen in these cancer cells and contribute to self-renewing divisions and cancer cell survival. In particular, high expression of Bmi-1 (B lymphoma mouse Moloney leukemia virus insertion region), a …
Characterizing And Inhibiting Two Pathways Activated In Glioblastoma Multiforme, Andrea Jydstrup, Sheri L. Holmen
Characterizing And Inhibiting Two Pathways Activated In Glioblastoma Multiforme, Andrea Jydstrup, Sheri L. Holmen
Undergraduate Research Opportunities Program (UROP)
Despite major improvements in imaging, radiation, and surgery, the prognosis for patients with Glioblastoma multiforme (GBM) remains clinically challenging. New treatment strategies are badly needed to reduce the mortality and morbidity associated with this disease. The resistance of these tumors to conventional treatments makes GBM patients ideal candidates for molecularly targeted therapies and several agents are currently being developed(1). Because GBM is genetically heterogeneous, combination therapies or the use of multikinase inhibitors are more likely to achieve the greatest therapeutic benefit(2,3). However, genes that can be productively targeted for effective therapies in patients remain to be identified. The overall objective …